Rankings
▼
Calendar
QTTB FY 2024 Earnings — Q32 Bio Inc. Revenue & Financial Results | Market Cap Arena
QTTB
Q32 Bio Inc.
$73M
FY 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
+100.0% YoY
Gross Profit
-$487,000
Operating Income
-$66M
Net Income
-$48M
EPS (Diluted)
$-6.58
Cash Flow
Operating Cash Flow
-$68M
Free Cash Flow
-$68M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$92M
Total Liabilities
$87M
Stockholders' Equity
$6M
Cash & Equivalents
$78M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
-$7M
+100.0%
Gross Profit
-$487,000
-$7M
+92.7%
Operating Income
-$66M
-$48M
-37.0%
Net Income
-$48M
-$54M
+11.2%
← Q4 2023
All Quarters
Q1 2024 →